HTR1A and Parkinson disease: Stimulation of 5-HT1A receptor is associated with an increase in dopamine turnover (12), dopaminergic cell firing (13) and dopamine release (14) suggesting that 5-HT1A agonists might have potential therapeutic value in the treatment of Parkinson’s disease.